MasterPharm Recalls Formula 82F Minoxidil Tretinoin Fluocinolone Acetonide Finasteride
MasterPharm LLC is recalling 462 units of Formula 82F topical solution due to a lack of processing controls that compromised product specifications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of processing controls without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
MasterPharm LLC is voluntarily recalling 462 units of Formula 82F (Minoxidil 5%/Tretinoin 0.01%/Fluocinolone Acetonide 0.01%/Finasteride 0.25%), 0.5 FL OZ (15 mL) bottles. The recall was initiated because of a lack of processing controls, which means there was a lack of assurance that the product conformed to its specifications.
The affected product was distributed nationwide in the U.S. The specific lots involved include those with manufacturing dates of 01-15-2020, 01-09-2020, 01-20-2020, 01-23-2020, 01-29-2020, and 02-03-2020, with corresponding best-use dates ranging from July 2020 to late July 2020.
Consumers who have this product should stop using it and contact MasterPharm LLC at (866) 630-5600 for instructions on how to return the product or obtain a refund.
The recalled product
- Product
- Formula 82F (Minoxidil 5%/Tretinoin 0.01%/Fluocinolone Acetonide 0.01%/Finasteride 0.25%), 0.5 FL OZ (15 mL) bottle MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600.
- Manufacturer
- MasterPharm LLC
- Category
- Drug — Topical Prescription
- Affected units
- 462
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- 01-15-2020:70@3
- 01-09-2020:48@2
- BUD 7/7/2020 01-20-2020:79@11
- 01-23-2020:55@11
- BUD 7/18/2020 01-29-2020:18@1
- 02-03-2020:89@8
- BUD 7/26/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by MasterPharm LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
Same hazard · quality control
See all →- HighBaxter Recalls CARDENE IV Nicardipine Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateMylan Recalls Mycophenolate Mofetil Injection Due to Dissolution Failures
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls MYXREDLIN Insulin Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereMasterPharm Recalls Finasteride Plus Capsules Due to Minoxidil Contamination
FDA (Drugs) · 2020-05-20
- SevereMasterPharm Recalls Compounded Minoxidil, Biotin, and Spironolactone Capsules
FDA (Drugs) · 2020-07-08
- ModerateLupin Recalls Fluocinolone Acetonide Topical Solution Due to Impurity Failures
FDA (Drugs) · 2018-10-31
- ModerateLupin Recalls Fluocinolone Acetonide Topical Solution Due to Impurities
FDA (Drugs) · 2019-01-30
- ModerateTeva Recalls Fluocinolone Acetonide Topical Solution for Impurity and Potency Issues
FDA (Drugs) · 2018-07-18
- ModerateFluocinolone topical solution recalled after failing an impurity specification
FDA (Drugs) · 2026-01-21